Skip to main content

Lucid Diagnostics Inc 8-K, filed Nov 12, 2026

Lucid Diagnostics Inc. (LUCD)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Lucid Diagnostics Inc filed this 8-K on November 12, 2026.

Lucid Diagnostics Inc. said EsoGuard is now fully reimbursed nationwide by Medicare, received its first Medicare payments in October at $1,938.01 per test, and recorded $1.2 million in third-quarter revenue. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits